Organizing Committee Members Series of - Pharmaceutical Microbiology Conferences
International Committee
Dennis Owens
Executive Recrutier /Senior Microbiologist
Jeff Smith & Associates Inc.
USA
Dennis Owens (Biography)
Dennis has had a varied career in the water, wastewater and environmental consulting fields. As a graduate of the Texas Tech University with a B.S and M.Sc. in Chemistry / Microbiology, Dennis has been a consultant for most of his career, and in this capacity has established a broad contact base. Dennis is the Senior Microbiologist / Chemist for SWT Consulting Inc. a firm specializing in water and wastewater treatment as well as water reuse technologies.
Dennis Owens (Research Area)
Waste water and Environmental Consulting
Hope Mueller
Vice President
Horizon Pharma plc
United States
Hope Mueller (Biography)
Dr.Hope Mueller is currently working as an Vice president in the Horizon Pharma Plc.
Hope Mueller (Research Area)
Quality Assurance.
Soumeya Bouaroudj
Expert Consultant Microbiologist
Novo Nordisk,Baxter
Switzerland
Soumeya Bouaroudj(Biography)
Dr.Soumeya Bouaroudi is currently working as an Expert Quality Management of Non-Conformities in Novo Nordisk,France.She completed her Masters degree from the University Louis Pasteur ,Strasboug in the field of Cellular Biology and Physiology from 2001-2002.She worked as an Assistant Microbiology Professor in the University Louis Pasteur from 2000-2002 and also the Assistant Microbiology Engineer in TEPRAL from 2002-2003.She workrd as an Quality Assurance/Quality Control Microbiology Team Leader /Scientific Expert/Technical Coordinator in Novartis,France from 2008-2011.In 2012,She served as an Quality Control Microbiology Expert in Johnson -Johnson ,Switzerland.
Soumeya Bouaroudj(Research Area)
Quality Assurance
Isam Pharma Mustafa
Director of Pharmaceutical Services
Utrecht University
Switzerland
Isam Pharma Mustafa(Biography)
Dr.Isam Pharma Mustafa is currently working as an Director of Pharmaceutical Services at National Health Insurance Fund ,Sudan.
Isam Pharma Mustafa(Research Area)
Pharmaceutical Microbiology
Ian James Martins
Chief-Editor
Edith Cowan University,Australia
Australia
Ian James Martins (Biography)
Dr. Ian Martins has been invited to join the Editors of various international journals and has been a reviewer for various journals (approx. 40). He was appointed as the Chief Editor for International Journal of Diabetes Research (2014-2017). He is a BIT Member (BIT Congress. Inc) with an H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). The total citations over the past 27 years of scientific research has accumulated to 2977. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name places Dr Martins’ publication stats RG score higher than 96% of the international researchers and is now a SCIENTIST (ResearchGate). He is now a Scientist for The Science Advisory Board (USA). He has reached the top 3% of Academia.edu. researchers and is a connecting researcher with ORCID. Prevention of over eating by food restriction improves liver lipid metabolism and nature of fat consumed is important to improving health. Contribution to biology is the peripheral sink abeta hypothesis and its relevance to organ suicide, diabetes and Alzheimer’s disease. Dr Martins has received certificates of recognition at various international conferences, world congress and conventions in relation to anti-aging, health and disease. Keynote addresses at Innovate Pharma 2017, Innovate Neurology 2017, World Diabetes and Endocrinology Summit-2017 and Pharmacology and Ethnopharmacology 2016 has been completed with relevance to the current global epidemic on chronic diseases. Invited 1st Plenary Speaker at the Annual Global Health Conference 2016 with relevance to “Nutritional diets accelerate amyloid beta metabolism and prevent the induction of chronic diseases and Alzheimer’s disease. Photon ebooks†(Dr Ian Martins was conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM).
Ian James Martins (Research Area)
His current research into links between diet, diabetes and neurodegenerative diseases builds upon his past experiences and generates outputs that will have relevant and significant impact to the community. The incidence of diabetes has been predicted to increase to 21% by 2050. In various continents the rise in the global diabetes epidemic has been associated with diseases of various organ diseases related to obesity, diabetes and neurodegenerative diseases (Parkinson’s disease and Alzheimer’s disease). Novel and critical elements of scholarly peer review provides information that the heat shock gene Sirtuin 1 is repressed with relevance to diabetes, neurological diseases and Alzheimer's disease. Major unsolved challenges to advances in biology may now provide evidence to reverse Sirtuin 1 dysfunction that is connected to primarly to heat shock protein metabolism and secondly to toxic amyloid beta metabolism with mitochondrial apoptosis in liver and brain cells. In the developing world increased levels of bacterial lipopolysaccharides repress the anti-aging gene Sirtuin 1 with the development of diabetes, neurodegenerative diseases and Alzheimer’s disease. Unhealthy diets accelerate Type 3 diabetes with the induction of NAFLD in Global Populations.